Further studies have shown that the in vitro and in vivo inactivation of type I IFN signaling by using shIFNAR1 cells and IFNAR1-null mice, respectively, overcome oncogene-induced senescence, a tumor-suppressive signal that protects DNA-damaged cells from the onset of melanoma. This evidence concerns the gene IFNAR1 and melanoma.